MXPA05010480A - Compuestos que se enlazan a la histamina, para el tratamiento de condiciones de enfermedad mediadas por neutrofilos. - Google Patents
Compuestos que se enlazan a la histamina, para el tratamiento de condiciones de enfermedad mediadas por neutrofilos.Info
- Publication number
- MXPA05010480A MXPA05010480A MXPA05010480A MXPA05010480A MXPA05010480A MX PA05010480 A MXPA05010480 A MX PA05010480A MX PA05010480 A MXPA05010480 A MX PA05010480A MX PA05010480 A MXPA05010480 A MX PA05010480A MX PA05010480 A MXPA05010480 A MX PA05010480A
- Authority
- MX
- Mexico
- Prior art keywords
- disease conditions
- neutrophils
- treatment method
- binding compounds
- conditions mediated
- Prior art date
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229960001340 histamine Drugs 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title abstract 2
- 210000000440 neutrophil Anatomy 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a un novedoso metodo para el tratamiento de condiciones de enfermedad que son mediadas por celulas neutrofilas. El metodos involucra administrarle a un paciente que sufre de tal condicion, un compuesto que se enlaza a la histamina, en una cantidad terapeuticamente efectiva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307544.7A GB0307544D0 (en) | 2003-04-01 | 2003-04-01 | Treatment method |
| PCT/GB2004/001428 WO2004087188A1 (en) | 2003-04-01 | 2004-04-01 | Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05010480A true MXPA05010480A (es) | 2005-11-16 |
Family
ID=9955988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05010480A MXPA05010480A (es) | 2003-04-01 | 2004-04-01 | Compuestos que se enlazan a la histamina, para el tratamiento de condiciones de enfermedad mediadas por neutrofilos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070249528A1 (es) |
| EP (1) | EP1613336A1 (es) |
| JP (1) | JP2006522083A (es) |
| CN (1) | CN1795008A (es) |
| AU (1) | AU2004226697B2 (es) |
| BR (1) | BRPI0408984A (es) |
| CA (1) | CA2520580A1 (es) |
| GB (1) | GB0307544D0 (es) |
| MX (1) | MXPA05010480A (es) |
| NZ (1) | NZ542831A (es) |
| WO (1) | WO2004087188A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0522298D0 (en) | 2005-11-01 | 2005-12-07 | Natural Environment Res | Agents that bind IgE |
| GB0809279D0 (en) * | 2008-05-21 | 2008-06-25 | Varleigh Ltd | Histamine binding protein |
| GB201720505D0 (en) * | 2017-12-08 | 2018-01-24 | Volution Immuno Pharmaceuticals Sa | Methods for treatment of neuropathic pain |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997044451A2 (en) * | 1996-05-18 | 1997-11-27 | Oxford Vacs Ltd. | Vasoactive amine binding molecules |
| EP1034273B1 (en) * | 1997-11-26 | 2006-12-27 | Evolutec Limited | Histamine and serotonin binding molecules |
| GB9920674D0 (en) * | 1999-09-01 | 1999-11-03 | Evolutec Limited | Treatment of conjunctivitis |
| GB9920673D0 (en) * | 1999-09-01 | 1999-11-03 | Evolutec Limited | Treatment of allergic rhinitis |
| WO2001040469A2 (en) * | 1999-12-03 | 2001-06-07 | Yale University | Tick antigens and compositions and methods comprising them |
-
2003
- 2003-04-01 GB GBGB0307544.7A patent/GB0307544D0/en not_active Ceased
-
2004
- 2004-04-01 JP JP2006506075A patent/JP2006522083A/ja active Pending
- 2004-04-01 MX MXPA05010480A patent/MXPA05010480A/es not_active Application Discontinuation
- 2004-04-01 CN CNA2004800145698A patent/CN1795008A/zh active Pending
- 2004-04-01 AU AU2004226697A patent/AU2004226697B2/en not_active Ceased
- 2004-04-01 CA CA002520580A patent/CA2520580A1/en not_active Abandoned
- 2004-04-01 NZ NZ542831A patent/NZ542831A/en unknown
- 2004-04-01 BR BRPI0408984-7A patent/BRPI0408984A/pt not_active IP Right Cessation
- 2004-04-01 US US10/551,482 patent/US20070249528A1/en not_active Abandoned
- 2004-04-01 EP EP04725105A patent/EP1613336A1/en not_active Withdrawn
- 2004-04-01 WO PCT/GB2004/001428 patent/WO2004087188A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004226697B2 (en) | 2010-05-13 |
| US20070249528A1 (en) | 2007-10-25 |
| BRPI0408984A (pt) | 2006-03-28 |
| EP1613336A1 (en) | 2006-01-11 |
| AU2004226697A1 (en) | 2004-10-14 |
| CN1795008A (zh) | 2006-06-28 |
| GB0307544D0 (en) | 2003-05-07 |
| NZ542831A (en) | 2007-06-29 |
| JP2006522083A (ja) | 2006-09-28 |
| WO2004087188A1 (en) | 2004-10-14 |
| CA2520580A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006037024A3 (en) | Salts of decitabine | |
| WO2006008028A8 (de) | Neue 6-formyl-tetrahydropteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, u.a. gegen krebs | |
| UA92355C2 (en) | urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS | |
| SG147444A1 (en) | Anti-ox40l antibodies | |
| WO2005090333A8 (en) | 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
| WO2006034154A3 (en) | Salts of 5-azacytidine | |
| WO2008001101A3 (en) | Pharmaceutical combinations | |
| WO2005067893A3 (en) | Pharmaceutical compositions comprising midazolam in a high concentration | |
| WO2004045523A3 (en) | Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders | |
| WO2008005266A3 (en) | Method of using substituted piperidines that increase p53 activity | |
| SG160412A1 (en) | Anti-igfr1 antibody therapeutic combinations | |
| WO2007022506A3 (en) | Methods and compositions for treating neurological disease | |
| UA87153C2 (ru) | Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы | |
| WO2008013987A3 (en) | N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones | |
| WO2003068746A8 (en) | Aryl ureas as kinase inhibitors | |
| MY145349A (en) | Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor | |
| EA200700273A1 (ru) | Способ лечения гиперфосфатемии c использованием гидроксикарбоната лантана | |
| WO2005023193A3 (en) | Methods of treating endometriosis | |
| TW200727908A (en) | Herbal composition for treating cancer | |
| WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy | |
| WO2006058720A3 (en) | Novel compounds for the treatment of neurological disorders | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| UA86399C2 (ru) | Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза | |
| TW200744577A (en) | Method for treating osteoarthritis | |
| WO2006031782A3 (en) | Salvinorin derivatives as opioid receptor ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |